Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-20 9:07 pm Sale | 2026-01-15 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 22,472,467 7.200% | -2,530,000 (-10.12%) | Filing History |
| 2025-12-23 5:49 pm Sale | 2025-12-23 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 6,211,854 4.980% | -850,000 (-12.04%) | Filing History |
| 2025-12-18 8:17 pm Purchase | 2025-12-16 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 25,002,467 8.100% | 382,206 (+1.55%) | Filing History |
| 2025-12-10 8:15 pm Sale | 2025-12-08 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 7,061,854 5.700% | -2,192,298 (-23.69%) | Filing History |
| 2025-12-01 8:04 pm Sale | 2025-11-26 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 24,620,261 7.900% | -101,539 (-0.41%) | Filing History |
| 2025-11-17 6:35 pm Purchase | 2025-11-13 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 24,721,800 8.000% | 6,398,423 (+34.92%) | Filing History |
| 2025-11-14 11:45 am Purchase | 2025-09-30 | 13G | Odyssey Marine Exploration, Inc. OMEX | Two Seas Capital LP | 5,084,883 9.990% | 1,930,075 (+61.18%) | Filing History |
| 2025-11-14 11:44 am Purchase | 2025-09-30 | 13G | Veradigm Inc. MDRX | Two Seas Capital LP | 5,823,328 5.300% | 5,823,328 (New Position) | Filing History |
| 2025-11-14 11:43 am Sale | 2025-09-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 9,749,724 4.700% | -205,251 (-2.06%) | Filing History |
| 2025-11-14 11:42 am Sale | 2025-09-30 | 13G | Adaptimmune Therapeutics plc ADAPY | Two Seas Capital LP | 0 0.000% | -135,484,206 (Position Closed) | Filing History |
| 2025-11-14 11:41 am Purchase | 2025-09-30 | 13G | Calumet, Inc. CLMT | Two Seas Capital LP | 6,752,538 7.800% | 2,254,929 (+50.14%) | Filing History |
| 2025-11-14 11:39 am Purchase | 2025-09-30 | 13G | USA TODAY Co., Inc. TDAY | Two Seas Capital LP | 14,180,621 9.600% | 2,950,000 (+26.27%) | Filing History |
| 2025-11-05 8:21 pm Sale | 2025-11-03 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 9,254,152 7.400% | -1,075,000 (-10.41%) | Filing History |
| 2025-10-31 5:16 pm Sale | 2025-10-29 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 18,323,377 5.900% | -1,579,247 (-7.93%) | Filing History |
| 2025-10-09 7:39 pm Purchase | 2025-10-07 | 13D | Core Scientific, Inc. CORZ | Two Seas Capital LP | 19,902,624 6.500% | 779,782 (+4.08%) | Filing History |
| 2025-09-05 4:13 pm Sale | 2025-09-03 | 13D | Indivior Pharmaceuticals Inc INDV | Two Seas Capital LP | 10,329,152 8.300% | -1,333,156 (-11.43%) | Filing History |
| 2025-08-13 5:47 pm Purchase | 2025-06-30 | 13G | Esperion Therapeutics, Inc. ESPR | Two Seas Capital LP | 9,954,975 5.000% | 3,370,697 (+51.19%) | Filing History |
| 2025-08-13 5:46 pm Purchase | 2025-06-30 | 13G | USA TODAY Co., Inc. TDAY | Two Seas Capital LP | 11,230,621 7.700% | 11,230,621 (New Position) | Filing History |
| 2025-08-13 5:44 pm Purchase | 2025-06-30 | 13G | Calumet, Inc. CLMT | Two Seas Capital LP | 4,497,609 5.200% | 4,497,609 (New Position) | Filing History |
| 2025-08-13 5:43 pm Purchase | 2025-06-30 | 13G | Adaptimmune Therapeutics plc ADAPY | Two Seas Capital LP | 135,484,206 8.500% | 12,306,096 (+9.99%) | Filing History |